Cypress Semiconductor Corp. (NASDAQ:CY) today announced fourth-quarter
2011 and fiscal year 2011 results, which included the following
highlights and remarks from its president and CEO, T.J. Rodgers.
-
Revenue and earnings exceed guidance
-
TrueTouch® revenue exceeds top end of $230 to $250 million
annual target
-
Handset revenues increased 140% year over year
-
Revenue increased 13% year over year
-
Cash flow from operations totaled $284.2 million for 2011
Fellow shareholders:
Our revenue and earnings for the quarter are given below, compared with
the prior-quarter and prior-year results:
|
(In thousands, except per-share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-GAAP
|
|
|
GAAP
|
|
|
|
|
Q4 2011
|
|
Q3 2011
|
|
Q4 2010
|
|
|
Q4 2011
|
|
Q3 2011
|
|
Q4 2010
|
|
Revenue
|
|
|
$242,372
|
|
$264,743
|
|
$226,564
|
|
|
$242,372
|
|
$264,743
|
|
$220,314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
56.1%
|
|
57.9%
|
|
59.2%
|
|
|
53.6%
|
|
56.3%
|
|
55.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pretax margin
|
|
|
22.6%
|
|
26.8%
|
|
23.1%
|
|
|
11.7%
|
|
16.6%
|
|
8.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
$56,119
|
|
$69,237
|
|
$50,389
|
|
|
$30,961
|
|
$39,981
|
|
$9,053
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS
|
|
|
$0.32
|
|
$0.37
|
|
$0.25
|
|
|
$0.18
|
|
$0.22
|
|
$0.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our fourth-quarter revenue exceeded the high end of guidance, decreased
8.5% sequentially and grew 10.0% year-on-year. All core divisions and
most major product lines decreased sequentially as expected. We continue
to focus on operating expense control and even in a challenging revenue
quarter our non-GAAP EPS grew 28% year over year. Inventory decreased
17.3% sequentially, and inventory in the supply chain remains very low.
For fiscal year 2011, Cypress posted total revenue of $995.2 million, an
increase of 13.4% from fiscal year 2010 revenue of $877.5 million. On a
non-GAAP1 basis, Cypress’s fiscal year 2011 diluted earnings
per share was $1.24, compared with diluted earnings per share of $0.94
in 2010, an increase of 32%. On a GAAP basis, Cypress’s fiscal year 2011
diluted net earnings per share was $0.89, compared with diluted net
earnings per share of $0.40 in 2010.
Booking visibility will remain limited into Q1 due to historically low
lead-times, continued inventory adjustments and ongoing concerns over
worldwide macroeconomic issues. Our book-to-bill ratio for Q4 was 0.58,
a decrease from that of Q3 and less than the normal seasonal figure.
Consequently, we expect Q1 revenue also to decrease at a rate greater
than normal. The expected decrease in revenue includes not only the
seasonal factor, but also some revenue decreases due to tablet end
sales. Assuming no further macroeconomic deterioration, we expect that
bookings and revenue will bottom out in Q1 2012 and lead to a strong
second half as many new product design wins ramp into production.
Cypress posted a very good year in 2011, especially considering the
macroeconomic cloud that has hung over the industry for the last six
plus months. The performance of our broad base of proprietary and
TrueTouch products led to a 13% revenue increase, double the industry
growth rate.
Our non-GAAP EPS increased 32.0% year over year, and our cash flow from
operations in 2011 enabled us to return $672.9 million dollars to our
shareholders by purchasing 36 million shares and initiating a $0.36
annualized dividend per share that yielded approximately 2.2% for the
year.
BUSINESS REVIEW
+ Our non-GAAP1 consolidated gross margin for the fourth
quarter was 56.1%, down 1.8 percentage points from the previous quarter
due mainly to product mix and factory absorption. Our GAAP
fourth-quarter consolidated gross margin was 53.6%.
+ Our net inventory dollars at the end of the fourth quarter were down
17.3% relative to Q3, and our inventory days were down by 12 days to 79
days.
+ Cash and investments for the fourth quarter totaled $166.3 million, an
increase of $31.3 million from the prior quarter, and equivalent to
approximately $1.08 per outstanding share. During the quarter, we bought
back 4.0 million shares of common stock (2.3% of total outstanding
shares) for $62.8 million at an average price of $15.82 per share. Since
we announced our $400-million stock repurchase program in September
2011, we have repurchased 5.1 million shares through January 12, 2012
and have approximately $318.9 million left for additional repurchases.
Our divisional revenue and gross margins are detailed below:
|
|
|
BUSINESS UNIT SUMMARY FINANCIALS (UNAUDITED)
|
|
|
|
|
|
|
|
THREE MONTHS ENDED
January 1, 2012
|
|
|
|
|
|
CCD 2
|
|
DCD 2
|
|
MPD 2
|
|
Core Semi 4
|
|
Emerging Tech. 3
|
|
Consolidated
|
|
|
|
REVENUE ($M)
|
|
130.7
|
|
22.7
|
|
80.6
|
|
234.0
|
|
8.4
|
|
242.4
|
|
|
|
Percentage of total revenues
|
|
53.9%
|
|
9.3%
|
|
33.3%
|
|
96.5%
|
|
3.5%
|
|
100.0%
|
|
|
|
|
|
|
|
GROSS MARGIN (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On a GAAP basis
|
|
52.4%
|
|
68.6%
|
|
53.6%
|
|
54.4%
|
|
29.7%
|
|
53.6%
|
|
|
|
On a non-GAAP1 basis
|
|
54.9%
|
|
71.1%
|
|
56.1%
|
|
56.9%
|
|
32.2%
|
|
56.1%
|
|
|
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED October 2, 2011
|
|
|
|
|
|
CCD 2
|
|
DCD 2
|
|
MPD 2
|
|
Core Semi 4
|
|
Emerging Tech. 3
|
|
Consolidated
|
|
|
|
REVENUE ($M)
|
|
142.1
|
|
23.6
|
|
92.5
|
|
258.2
|
|
6.5
|
|
264.7
|
|
|
|
Percentage of total revenues
|
|
53.7%
|
|
8.9%
|
|
34.9%
|
|
97.6%
|
|
2.4%
|
|
100.0%
|
|
|
|
|
|
|
|
GROSS MARGIN (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On a GAAP basis
|
|
56.4%
|
|
64.8%
|
|
56.3%
|
|
57.1%
|
|
22.8%
|
|
56.3%
|
|
|
|
On a non-GAAP1 basis
|
|
58.0%
|
|
66.5%
|
|
57.9%
|
|
58.8%
|
|
24.4%
|
|
57.9%
|
|
|
|
|
|
|
|
|
|
|
|
TWELVE MONTHS ENDED January 1, 2012
|
|
|
|
|
|
|
|
|
|
CCD 2
|
|
DCD 2
|
|
MPD 2
|
|
Core Semi 4
|
|
Emerging Tech. 3
|
|
Consolidated
|
|
|
|
GAAP REVENUE ($M)
|
|
511.7
|
|
100.0
|
|
352.1
|
|
963.8
|
|
31.4
|
|
995.2
|
|
|
|
Percentage of total revenues
|
|
51.4%
|
|
10.0%
|
|
35.4%
|
|
96.8%
|
|
3.2%
|
|
100.0%
|
|
|
|
|
|
|
|
GROSS MARGIN (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On a GAAP basis
|
|
54.9%
|
|
64.6%
|
|
55.5%
|
|
56.1%
|
|
28.5%
|
|
55.3%
|
|
|
|
On a non-GAAP1 basis
|
|
57.3%
|
|
67.1%
|
|
56.9%
|
|
58.2%
|
|
30.9%
|
|
57.3%
|
|
|
|
|
|
|
|
|
|
|
|
TWELVE MONTHS ENDED January 2, 2011
|
|
|
|
|
|
|
|
|
|
CCD 2
|
|
DCD 2
|
|
MPD 2
|
|
Core Semi 4
|
|
Emerging Tech. 3
|
|
Consolidated
|
|
|
|
GAAP REVENUE ($M)
|
|
343.2
|
|
110.6
|
|
405.9
|
|
859.7
|
|
17.8
|
|
877.5
|
|
|
|
Percentage of total revenues
|
|
39.1%
|
|
12.6%
|
|
46.3%
|
|
98.0%
|
|
2.0%
|
|
100.0%
|
|
|
|
|
|
|
|
NON-GAAP REVENUE ($M)
|
|
343.2
|
|
110.6
|
|
412.2
|
|
866.0
|
|
17.8
|
|
883.8
|
|
|
|
Percentage of total revenues
|
|
38.8%
|
|
12.5%
|
|
46.7%
|
|
98.0%
|
|
2.0%
|
|
100.0%
|
|
|
|
|
|
|
|
GROSS MARGIN (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On a GAAP basis
|
|
57.7%
|
|
68.8%
|
|
52.1%
|
|
56.5%
|
|
19.9%
|
|
55.7%
|
|
|
|
On a non-GAAP1 basis
|
|
60.3%
|
|
71.4%
|
|
55.4%
|
|
59.4%
|
|
22.4%
|
|
58.7%
|
|
|
|
|
|
|
|
|
|
1.
|
|
Refer to "Reconciliation of GAAP Financial Measures to Non-GAAP
Financial Measures” and "Notes to Non-GAAP Financial Measures”
following this press release for a detailed discussion of
management’s use of non-GAAP financial measures, as well as
reconciliations of all non-GAAP financial measures presented in
this press release to the most directly comparable GAAP financial
measures.
|
|
|
|
|
|
2.
|
|
CCD – Consumer and Computation Division; DCD—Data Communications
Division; MPD—Memory Products Division.
|
|
|
|
|
|
3.
|
|
"Emerging Technology” – Businesses outside our core semiconductor
businesses outlined in footnote 4. Includes subsidiaries Cypress
Envirosystems and AgigA Tech, as well as the ONS (Optical
Navigation System) Business Unit, the China Business Unit and our
foundry-support business.
|
|
|
|
|
|
4.
|
|
"Core Semiconductor” – Includes CCD, DCD and MPD and excludes
"Emerging Technology.”
|
|
|
|
|
FOURTH-QUARTER 2011 HIGHLIGHTS
+ Cypress announced that its industry-leading Gen4 family of TrueTouch
touchscreen controllers is in production ahead of schedule, and that
initial production shipments have begun. Gen4 delivers industry-best
performance in all measurable touch categories, including the world's
best Signal-to-Noise Ratio (SNR) and unparalleled performance in the
presence of noise sources. Noise is the biggest challenge faced by
touchscreen designers. The unprecedented noise immunity offered by our
Gen4 family enables manufacturers to eliminate air gaps and shields in
displays and produce thinner, sleeker, less expensive cell phone designs.
+ Cypress expanded its Gen4 TrueTouch controller family, adding a new
member that targets displays up to 12 inches used in the fast-growing
tablet and ultrabook PC market. Like smaller-screen Gen4 devices, it
offers industry-best performance in all categories, including SNR and
noise immunity. Gen4 also has the industry’s lowest active power
consumption of just 3.6 milliwatts, best tracking accuracy, and fastest
screen refresh rates. It provides full support for major mobile
operating systems including Win8 and Android.
+ NVIDIA® certified Cypress’s new single-chip TrueTouch
solution on the reference design for its NVIDIA Tegra® 3
quad-core mobile processor. The design supports large touchscreens,
including next-generation Android 4.0 (Ice Cream Sandwich)-based tablets.
+ Cypress announced that its single-chip, large-touchscreen, Gen4
TrueTouch controllers also enable sensor-on-lens technology with direct
lamination to the LCD. The controllers enable manufacturers to deposit
conductive Indium Tin Oxide (ITO) touch sensor lines directly onto the
cover glass, so tablets can be made thinner, cheaper, and with fewer
manufacturing steps.
+ Cypress unveiled Tx-Boost™, a breakthrough feature for its Gen4
TrueTouch touchscreen controllers that dramatically improves system
performance without added cost. Based on Gen4’s patent-pending,
high-voltage Tx drivers, Tx-Boost delivers three times higher
Signal-to-Noise ratio without the use of digital filters, enabling the
industry’s thinnest devices while reducing materials cost. It also
reduces power consumption and increases scan rates. Cypress accomplishes
this without large, expensive, and noisy external switching regulators
needed by competitors to generate high-voltage Tx signaling.
+ Cypress announced official USB-IF certification of its two SuperSpeed
USB 3.0 peripheral controllers, EZ-USB® FX3 and West Bridge®
Benicia™, both of which are in full production. EZ-USB FX3, one of the
first USB 3.0 peripheral controllers in the industry, is also the only
programmable USB 3.0 solution available from any source. Its integrated,
highly flexible features enable developers to add 5-Gbps USB 3.0
connectivity to any system. West Bridge Benicia enables mobile devices
to double input/output performance, stream high-definition video,
"side-load” multimedia content at up to 160 Mbytes per second, and
reduce battery charging time by 50 percent.
+ Cypress announced that the next generation of its revolutionary PSoC
Creator™ software – the design environment for its PSoC® 3
and PSoC 5 programmable system-on-chip families – is available at www.cypress.com/go/psoccreator.
Among hundreds of new features in the new version, PSoC Creator 2.0
supports the ARM-based PSoC 5 architecture and the popular Keil µVision®
4 software.
+ Cypress introduced the new CY8CKIT-025 Development Kit for its PSoC 3
and PSoC 5 programmable system-on-chip architectures. The new kit
highlights PSoC’s unique, programmable 8- to 20-bit Delta-Sigma ADC that
allows tradeoffs between speed and accuracy.
+ Cypress announced that Sonoma Wire Works selected the PSoC 3 solution
for its new GuitarJack Model 2, which connects a musical instrument,
microphone, or audio hardware with Apple products such as the iPod
touch, iPhone or iPad.
+ Cypress unveiled a new subsidiary, Deca Technologies, part of its
Emerging Technology Division. Deca designs and manufactures breakthrough
electronic interconnect solutions—microwiring that links ever-smaller
generations of integrated circuits and packages to small-form-factor
electronic products such as smartphones. Deca leverages the unique,
cost-effective solar wafer manufacturing technology of SunPower Corp.
Its initial products include Wafer Level Chip Scale Packaging (WLCSP)
derivatives targeting the $1 billion-plus Wafer Level Packaging (WLP)
market. Deca aims to leverage its technology to integrate the dissimilar
chips used in next-generation systems.
+ Cypress announced that Avago Technologies Inc. has dropped its lawsuit
against Cypress. The lawsuit had claimed that Cypress’s OvationONS®
products infringed Avago optical navigation patents. Cypress paid no
damages and admitted to no infringement in the case. Cypress uses its
own, patented OptiCheck™ technology in OvationONS products, which enable
finger navigation in handheld devices.
ABOUT CYPRESS
Cypress delivers high-performance, mixed-signal, programmable solutions
that provide customers with rapid time-to-market and exceptional system
value. Cypress offerings include the flagship PSoC®
programmable system-on-chip families and derivatives such as PowerPSoC®
solutions for high-voltage and LED lighting applications, CapSense®
touch sensing and TrueTouch solutions for touchscreens. Cypress is the
world leader in USB controllers, including the high-performance West
Bridge® solution that enhances connectivity and performance
in multimedia handsets. Cypress is also a leader in high-performance
memories and programmable timing devices. Cypress serves numerous
markets including consumer, mobile handsets, computation, data
communications, automotive, industrial and military. Cypress trades on
the Nasdaq Global Select Market under the ticker symbol CY. Visit
Cypress online at www.cypress.com.
FORWARD-LOOKING STATEMENTS
Statements herein that are not historical facts and that refer to
Cypress or its subsidiaries’ plans and expectations for the remainder of
fiscal year 2011 and the future are forward-looking statements made
pursuant to the Private Securities Litigation Reform Act of 1995. We may
use words such as "believe,” "expect,” "future,” "plan,” "intend” and
similar expressions to identify such forward-looking statements that
include, but are not limited to, statements related to the semiconductor
market, the strength and growth of our proprietary and programmable
products, including our TrueTouch and PSoC product families, our
expectations regarding our Q112 revenue, bookings and earnings, our
expected financial results in the second half of fiscal 2012, the demand
and growth in the markets Cypress and its subsidiaries serve, including
touchscreens, our booking visibility, the expected performance of our
products, the production schedule for our Gen4 touchscreen controllers
and our focus on controlling operating expenses. Such statements reflect
our current expectations, which are based on information and data
available to our management as of the date of this release. Our actual
results may differ materially due to a variety of uncertainties and risk
factors, including but not limited to the state of and future of the
global economy, business conditions and growth trends in the
semiconductor market, the timing and success of our launch of Gen4
family of TrueTouch controllers, our ability to enter into new markets
with our portfolio of products, whether our products perform as
expected, whether the demand for our proprietary and programmable
products, including our TrueTouch and PSoC products, is fully realized,
whether our product and design wins result in increased sales, further
decreases in lead-time, additional inventory adjustments, worldwide
macroeconomic issues customer acceptance of Cypress and its
subsidiaries’ products, seasonality in the markets we serve, our ability
to achieve lower operating expenses and maintain a solid balance sheet,
any impact to sales due to the recent U.S. International Trade
Commission ruling in Apple Inc.
v. HTC Corp. et al, the actions
of our competitors, the behavior of our supply chain, our ability to
manage our business to have strong earnings and cash flow leverage,
factory utilization, the strength or softness of the markets we serve
and whether those markets achieve expected growth, our ability to
maintain and improve our gross margins and realize our bookings, our
ability to continue to focus on fixed costs, the financial performance
of our subsidiaries and Emerging Technology Division, our ability to
outgrow the market in revenue once the economy recovers and other risks
described in our filings with the Securities and Exchange Commission. We
assume no responsibility to update any such forward-looking statements.
Cypress, the Cypress logo, TrueTouch, PSoC, CapSense, PowerPSoC, West
Bridge, EZ-USB and QDR are registered trademarks of Cypress
Semiconductor Corp. Programmable System-on-Chip, Tx-Boost, Benicia and
PSoC Creator are trademarks of Cypress Semiconductor Corp. All other
trademarks or registered trademarks are the property of their respective
owners.
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
January 1, 2012
|
|
January 2, 2011
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and short-term investments (a)
|
|
$
|
166,330
|
|
|
$
|
434,261
|
|
|
Accounts receivable, net
|
|
|
103,524
|
|
|
|
117,726
|
|
|
Inventories, net (b)
|
|
|
92,304
|
|
|
|
101,763
|
|
|
Property, plant and equipment, net
|
|
|
284,465
|
|
|
|
260,122
|
|
|
Goodwill and other intangible assets, net
|
|
|
40,462
|
|
|
|
44,335
|
|
|
Other assets
|
|
|
122,739
|
|
|
|
114,594
|
|
|
Total assets
|
|
$
|
809,824
|
|
|
$
|
1,072,801
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
52,868
|
|
|
$
|
59,817
|
|
|
Deferred income
|
|
|
150,568
|
|
|
|
131,757
|
|
|
Income tax liabilities
|
|
|
43,488
|
|
|
|
65,461
|
|
|
Other accrued liabilities
|
|
|
165,758
|
|
|
|
112,873
|
|
|
Total liabilities
|
|
|
412,682
|
|
|
|
369,908
|
|
|
Total Cypress stockholders' equity
|
|
|
399,568
|
|
|
|
704,436
|
|
|
Noncontrolling interest
|
|
|
(2,426
|
)
|
|
|
(1,543
|
)
|
|
Total equity
|
|
|
397,142
|
|
|
|
702,893
|
|
|
Total liabilities and equity
|
|
$
|
809,824
|
|
|
$
|
1,072,801
|
|
|
|
|
(a)
|
|
Cash, cash equivalents and short-term investments do not include $19
million and $24 million of auction rate securities which are
classified as long-term investments in "Other assets" as of January
1, 2012 and January 2, 2011, respectively.
|
|
|
|
|
|
(b)
|
|
Net inventories include $4.6 million and $6.2 million of capitalized
inventories related to stock compensation expense, as of January 1,
2012 and January 2, 2011, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
ON A GAAP BASIS
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Twelve Months Ended
|
|
|
|
January 1, 2012
|
|
October 2, 2011
|
|
January 2, 2011
|
|
January 1, 2012
|
|
January 2, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
242,372
|
|
|
$
|
264,743
|
|
|
$
|
220,314
|
|
|
$
|
995,204
|
|
|
$
|
877,532
|
|
Cost of revenues
|
|
|
112,538
|
|
|
|
115,789
|
|
|
|
97,256
|
|
|
|
448,619
|
|
|
|
388,358
|
|
Gross margin (a)
|
|
|
129,834
|
|
|
|
148,954
|
|
|
|
123,058
|
|
|
|
546,585
|
|
|
|
489,174
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
46,846
|
|
|
|
46,266
|
|
|
|
47,909
|
|
|
|
190,255
|
|
|
|
176,816
|
|
Selling, general and administrative
|
|
|
55,788
|
|
|
|
55,453
|
|
|
|
58,679
|
|
|
|
228,374
|
|
|
|
218,491
|
|
Amortization of acquisition-related intangibles
|
|
|
731
|
|
|
|
731
|
|
|
|
812
|
|
|
|
2,892
|
|
|
|
3,028
|
|
Restructuring charges (credits)
|
|
|
932
|
|
|
|
871
|
|
|
|
(283
|
)
|
|
|
6,336
|
|
|
|
2,975
|
|
Gain on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(34,291
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses, net
|
|
|
104,297
|
|
|
|
103,321
|
|
|
|
107,117
|
|
|
|
393,566
|
|
|
|
401,310
|
|
Operating income
|
|
|
25,537
|
|
|
|
45,633
|
|
|
|
15,941
|
|
|
|
153,019
|
|
|
|
87,864
|
|
Interest and other income (expense), net
|
|
|
2,791
|
|
|
|
(1,833
|
)
|
|
|
1,871
|
|
|
|
1,859
|
|
|
|
6,302
|
|
Income before income taxes
|
|
|
28,328
|
|
|
|
43,800
|
|
|
|
17,812
|
|
|
|
154,878
|
|
|
|
94,166
|
|
Income tax provision (benefit)
|
|
|
(2,353
|
)
|
|
|
4,057
|
|
|
|
9,134
|
|
|
|
(11,379
|
)
|
|
|
19,290
|
|
Income, net of taxes
|
|
|
30,681
|
|
|
|
39,743
|
|
|
|
8,678
|
|
|
|
166,257
|
|
|
|
74,876
|
|
Adjust for net loss attributable to noncontrolling interest
|
|
|
280
|
|
|
|
238
|
|
|
|
375
|
|
|
|
882
|
|
|
|
866
|
|
Net income attributable to Cypress
|
|
$
|
30,961
|
|
|
$
|
39,981
|
|
|
$
|
9,053
|
|
|
$
|
167,139
|
|
|
$
|
75,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share attributable to Cypress:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.20
|
|
|
$
|
0.24
|
|
|
$
|
0.05
|
|
|
$
|
1.02
|
|
|
$
|
0.47
|
|
Diluted
|
|
$
|
0.18
|
|
|
$
|
0.22
|
|
|
$
|
0.05
|
|
|
$
|
0.89
|
|
|
$
|
0.40
|
|
Shares used in net income per share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
154,045
|
|
|
|
163,867
|
|
|
|
165,873
|
|
|
|
164,495
|
|
|
|
161,114
|
|
Diluted
|
|
|
172,079
|
|
|
|
183,282
|
|
|
|
197,556
|
|
|
|
186,895
|
|
|
|
191,377
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL
MEASURES (a)
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended January 1, 2012
|
|
|
|
CCD (b)
|
|
DCD (b)
|
|
MPD (b)
|
|
Core Semi (c)
|
|
Emerging Technologies (d)
|
|
Consolidated
|
|
GAAP gross margin
|
|
$
|
68,578
|
|
|
$
|
15,548
|
|
|
$
|
43,209
|
|
|
$
|
127,335
|
|
|
$
|
2,499
|
|
|
$
|
129,834
|
|
|
Stock-based compensation expense
|
|
|
2,969
|
|
|
|
514
|
|
|
|
1,829
|
|
|
$
|
5,312
|
|
|
|
191
|
|
|
$
|
5,503
|
|
|
Changes in value of deferred compensation plan (e)
|
|
|
133
|
|
|
|
23
|
|
|
|
82
|
|
|
|
238
|
|
|
|
9
|
|
|
|
247
|
|
|
Impairment of assets and other
|
|
|
162
|
|
|
|
28
|
|
|
|
100
|
|
|
|
290
|
|
|
|
10
|
|
|
|
300
|
|
|
Non-GAAP gross margin
|
|
$
|
71,842
|
|
|
$
|
16,113
|
|
|
$
|
45,220
|
|
|
$
|
133,175
|
|
|
$
|
2,709
|
|
|
$
|
135,884
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended October 2, 2011
|
|
|
|
CCD (b)
|
|
DCD (b)
|
|
MPD (b)
|
|
Core Semi (c)
|
|
Emerging Technologies (d)
|
|
Consolidated
|
|
GAAP gross margin
|
|
$
|
80,112
|
|
|
$
|
15,326
|
|
|
$
|
52,049
|
|
|
$
|
147,487
|
|
|
$
|
1,467
|
|
|
$
|
148,954
|
|
|
Stock-based compensation expense
|
|
|
2,685
|
|
|
|
447
|
|
|
|
1,748
|
|
|
|
4,880
|
|
|
|
122
|
|
|
|
5,002
|
|
|
Changes in value of deferred compensation plan (e)
|
|
|
(301
|
)
|
|
|
(50
|
)
|
|
|
(196
|
)
|
|
|
(547
|
)
|
|
|
(14
|
)
|
|
|
(561
|
)
|
|
Non-GAAP gross margin
|
|
$
|
82,496
|
|
|
$
|
15,723
|
|
|
$
|
53,601
|
|
|
$
|
151,820
|
|
|
$
|
1,575
|
|
|
$
|
153,395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended January 2, 2011
|
|
|
|
CCD (b)
|
|
DCD (b)
|
|
MPD (b)
|
|
Core Semi (c)
|
|
Emerging Technologies (d)
|
|
Consolidated
|
|
GAAP gross margin
|
|
$
|
60,018
|
|
|
$
|
16,992
|
|
|
$
|
45,222
|
|
|
$
|
122,232
|
|
|
$
|
826
|
|
|
$
|
123,058
|
|
|
Stock-based compensation expense
|
|
|
1,952
|
|
|
|
491
|
|
|
|
1,863
|
|
|
|
4,306
|
|
|
|
76
|
|
|
|
4,382
|
|
|
Changes in value of deferred compensation plan (e)
|
|
|
88
|
|
|
|
22
|
|
|
|
82
|
|
|
|
192
|
|
|
|
4
|
|
|
|
196
|
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
6,250
|
|
|
|
6,250
|
|
|
|
-
|
|
|
|
6,250
|
|
|
Impairment of assets
|
|
|
133
|
|
|
|
34
|
|
|
|
127
|
|
|
|
294
|
|
|
|
5
|
|
|
|
299
|
|
|
Non-GAAP gross margin
|
|
$
|
62,191
|
|
|
$
|
17,539
|
|
|
$
|
53,544
|
|
|
$
|
133,274
|
|
|
$
|
911
|
|
|
$
|
134,185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended January 1, 2012
|
|
|
|
CCD (b)
|
|
DCD (b)
|
|
MPD (b)
|
|
Core Semi (c)
|
|
Emerging Technologies (d)
|
|
Consolidated
|
|
GAAP gross margin
|
|
$
|
280,942
|
|
|
$
|
64,643
|
|
|
$
|
192,051
|
|
|
$
|
537,636
|
|
|
$
|
8,949
|
|
|
$
|
546,585
|
|
|
Stock-based compensation expense
|
|
|
12,115
|
|
|
|
2,418
|
|
|
|
8,439
|
|
|
|
22,972
|
|
|
|
758
|
|
|
|
23,730
|
|
|
Changes in value of deferred compensation plan (e)
|
|
|
(74
|
)
|
|
|
(3
|
)
|
|
|
(34
|
)
|
|
|
(111
|
)
|
|
|
-
|
|
|
|
(111
|
)
|
|
Impairment of assets and other
|
|
|
133
|
|
|
|
21
|
|
|
|
75
|
|
|
|
229
|
|
|
|
8
|
|
|
|
237
|
|
|
Non-GAAP gross margin
|
|
$
|
293,116
|
|
|
$
|
67,079
|
|
|
$
|
200,531
|
|
|
$
|
560,726
|
|
|
$
|
9,715
|
|
|
$
|
570,441
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended January 2, 2011
|
|
|
|
CCD (b)
|
|
DCD (b)
|
|
MPD (b)
|
|
Core Semi (c)
|
|
Emerging Technologies (d)
|
|
Consolidated
|
|
GAAP gross margin
|
|
$
|
198,145
|
|
|
$
|
76,150
|
|
|
$
|
211,340
|
|
|
$
|
485,635
|
|
|
$
|
3,539
|
|
|
$
|
489,174
|
|
|
Stock-based compensation expense
|
|
|
8,645
|
|
|
|
2,879
|
|
|
|
10,735
|
|
|
|
22,259
|
|
|
|
457
|
|
|
|
22,716
|
|
|
Changes in value of deferred compensation plan (e)
|
|
|
171
|
|
|
|
41
|
|
|
|
151
|
|
|
|
363
|
|
|
|
7
|
|
|
|
370
|
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
6,250
|
|
|
|
6,250
|
|
|
|
-
|
|
|
|
6,250
|
|
|
Impairment of assets and other
|
|
|
99
|
|
|
|
23
|
|
|
|
88
|
|
|
|
210
|
|
|
|
3
|
|
|
|
213
|
|
|
Non-GAAP gross margin
|
|
$
|
207,060
|
|
|
$
|
79,093
|
|
|
$
|
228,564
|
|
|
$
|
514,717
|
|
|
$
|
4,006
|
|
|
$
|
518,723
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Please refer to the accompanying "Notes to Non-GAAP Financial
Measures" for a detailed discussion of management's use of
non-GAAP financial measures.
|
|
|
(b)
|
|
CCD - Consumer and Computation Division; DCD - Data Communications
Division; MPD - Memory Product Division.
|
|
|
(c)
|
|
"Core Semi” – Includes CCD, DCD and MPD divisions and excludes
"Emerging Technologies.”
|
|
|
|
|
(d)
|
|
"Emerging Technologies” – Activities outside our core
semiconductor businesses outlined in footnote (c). Includes wholly
owned subsidiaries
|
|
|
(e)
|
|
Consistent with current presentation, all prior periods have been
recast to reflect changes in deferred compensation plan as a
Non-GAAP adjustment.
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL
MEASURES (a)
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Twelve Months Ended
|
|
|
|
January 1, 2012
|
|
October 2, 2011
|
|
January 2, 2011
|
|
January 1, 2012
|
|
January 2, 2011
|
|
GAAP revenue
|
|
$
|
242,372
|
|
|
$
|
264,743
|
|
|
$
|
220,314
|
|
|
$
|
995,204
|
|
|
$
|
877,532
|
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
6,250
|
|
|
|
|
|
6,250
|
|
|
Non-GAAP revenue
|
|
$
|
242,372
|
|
|
$
|
264,743
|
|
|
$
|
226,564
|
|
|
$
|
995,204
|
|
|
$
|
883,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP research and development expenses
|
|
$
|
46,846
|
|
|
$
|
46,266
|
|
|
$
|
47,909
|
|
|
$
|
190,255
|
|
|
$
|
176,816
|
|
|
Stock-based compensation expense
|
|
|
(5,989
|
)
|
|
|
(5,894
|
)
|
|
|
(5,792
|
)
|
|
|
(24,296
|
)
|
|
|
(21,541
|
)
|
|
Acquisition-related expense
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
Changes in value of deferred compensation plan (b)
|
|
|
(524
|
)
|
|
|
1,204
|
|
|
|
(581
|
)
|
|
|
114
|
|
|
|
(961
|
)
|
|
Non-GAAP research and development expenses
|
|
$
|
40,333
|
|
|
$
|
41,576
|
|
|
$
|
41,536
|
|
|
$
|
166,073
|
|
|
$
|
154,312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP selling, general and administrative expenses
|
|
$
|
55,788
|
|
|
$
|
55,453
|
|
|
$
|
58,679
|
|
|
$
|
228,374
|
|
|
$
|
218,491
|
|
|
Stock-based compensation expense
|
|
|
(13,876
|
)
|
|
|
(13,939
|
)
|
|
|
(11,422
|
)
|
|
|
(52,754
|
)
|
|
|
(47,202
|
)
|
|
Acquisition-related expense
|
|
|
-
|
|
|
|
-
|
|
|
|
7
|
|
|
|
-
|
|
|
|
-
|
|
|
Changes in value of deferred compensation plan (b)
|
|
|
(1,084
|
)
|
|
|
2,464
|
|
|
|
(913
|
)
|
|
|
460
|
|
|
|
(1,727
|
)
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,000
|
)
|
|
|
-
|
|
|
|
(1,000
|
)
|
|
Building donation
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,125
|
)
|
|
|
-
|
|
|
Impairment of assets and other
|
|
|
(105
|
)
|
|
|
(1,982
|
)
|
|
|
(4,927
|
)
|
|
|
(3,809
|
)
|
|
|
(5,293
|
)
|
|
Non-GAAP selling, general and administrative expenses
|
|
$
|
40,723
|
|
|
$
|
41,996
|
|
|
$
|
40,424
|
|
|
$
|
168,146
|
|
|
$
|
163,269
|
|
|
|
|
|
.
|
|
|
|
|
|
|
|
|
|
|
GAAP operating income
|
|
$
|
25,537
|
|
|
$
|
45,633
|
|
|
$
|
15,941
|
|
|
$
|
153,019
|
|
|
$
|
87,864
|
|
|
Stock-based compensation expense
|
|
|
25,370
|
|
|
|
24,835
|
|
|
|
21,596
|
|
|
|
100,781
|
|
|
|
91,459
|
|
|
Gain on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(34,291
|
)
|
|
|
-
|
|
|
Acquisition-related expense
|
|
|
731
|
|
|
|
731
|
|
|
|
805
|
|
|
|
2,892
|
|
|
|
3,028
|
|
|
Changes in value of deferred compensation plan (b)
|
|
|
1,854
|
|
|
|
(4,229
|
)
|
|
|
1,689
|
|
|
|
(686
|
)
|
|
|
3,056
|
|
|
Restructuring charges (credits)
|
|
|
932
|
|
|
|
871
|
|
|
|
(283
|
)
|
|
|
6,336
|
|
|
|
2,975
|
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
7,250
|
|
|
|
-
|
|
|
|
7,250
|
|
|
Building donation
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
4,125
|
|
|
|
-
|
|
|
Impairment of assets and other
|
|
|
404
|
|
|
|
1,982
|
|
|
|
5,226
|
|
|
|
4,046
|
|
|
|
5,506
|
|
|
Non-GAAP operating income
|
|
$
|
54,828
|
|
|
$
|
69,823
|
|
|
$
|
52,224
|
|
|
$
|
236,222
|
|
|
$
|
201,138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income attributable to Cypress
|
|
$
|
30,961
|
|
|
$
|
39,981
|
|
|
$
|
9,053
|
|
|
$
|
167,139
|
|
|
$
|
75,742
|
|
|
Stock-based compensation expense
|
|
|
25,370
|
|
|
|
24,835
|
|
|
|
21,596
|
|
|
|
100,781
|
|
|
|
91,459
|
|
|
Gain on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(34,291
|
)
|
|
|
-
|
|
|
Acquisition-related expense
|
|
|
731
|
|
|
|
731
|
|
|
|
805
|
|
|
|
2,892
|
|
|
|
3,028
|
|
|
Changes in value of deferred compensation plan (b)
|
|
|
1,854
|
|
|
|
119
|
|
|
|
(1
|
)
|
|
|
(686
|
)
|
|
|
403
|
|
|
Restructuring charges (credits)
|
|
|
932
|
|
|
|
871
|
|
|
|
(283
|
)
|
|
|
6,336
|
|
|
|
2,975
|
|
|
Investment-related gains/losses
|
|
|
-
|
|
|
|
(1,538
|
)
|
|
|
400
|
|
|
|
-
|
|
|
|
(3,158
|
)
|
|
Changes in liability of deferred compensation plan
|
|
|
(2,005
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
808
|
|
|
|
-
|
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
7,250
|
|
|
|
-
|
|
|
|
7,250
|
|
|
Building donation
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
4,125
|
|
|
|
-
|
|
|
Impairment of assets and other
|
|
|
404
|
|
|
|
1,982
|
|
|
|
5,226
|
|
|
|
4,046
|
|
|
|
5,506
|
|
|
Tax effects
|
|
|
(2,128
|
)
|
|
|
2,256
|
|
|
|
6,343
|
|
|
|
(14,315
|
)
|
|
|
3,105
|
|
|
Non-GAAP net income attributable to Cypress
|
|
$
|
56,119
|
|
|
$
|
69,237
|
|
|
$
|
50,389
|
|
|
$
|
236,835
|
|
|
$
|
186,310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income per share attributable to Cypress - diluted
|
|
$
|
0.18
|
|
|
$
|
0.22
|
|
|
$
|
0.05
|
|
|
$
|
0.89
|
|
|
$
|
0.40
|
|
|
Stock-based compensation expense
|
|
|
0.15
|
|
|
|
0.13
|
|
|
|
0.11
|
|
|
|
0.53
|
|
|
|
0.45
|
|
|
Gain on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.18
|
)
|
|
|
-
|
|
|
Restructuring charges
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
-
|
|
|
|
0.03
|
|
|
|
0.01
|
|
|
Changes in value of deferred compensation plan (b)
|
|
|
0.01
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Acquisition related expense
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.02
|
|
|
|
0.01
|
|
|
Changes in liability of deferred compensation plan
|
|
|
(0.01
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Investment-related gains/losses
|
|
|
-
|
|
|
|
(0.01
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.02
|
)
|
|
SRAM legal settlement
|
|
|
-
|
|
|
|
-
|
|
|
|
0.04
|
|
|
|
-
|
|
|
|
0.04
|
|
|
Building donation
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
0.02
|
|
|
|
|
Impairment of assets and other
|
|
|
-
|
|
|
|
0.01
|
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.03
|
|
|
Tax effects
|
|
|
(0.01
|
)
|
|
|
0.01
|
|
|
|
0.03
|
|
|
|
(0.08
|
)
|
|
|
0.02
|
|
|
Non-GAAP share count adjustment
|
|
|
(0.01
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.01
|
)
|
|
|
-
|
|
|
Non-GAAP net income per share attributable to Cypress - diluted
|
|
$
|
0.32
|
|
|
$
|
0.37
|
|
|
$
|
0.25
|
|
|
$
|
1.24
|
|
|
$
|
0.94
|
|
|
|
|
(a)
|
|
Please refer to the accompanying "Notes to Non-GAAP Financial
Measures" for a detailed discussion of management's use of non-GAAP
financial measures.
|
|
(b)
|
|
Consistent with current presentation, all prior periods have been
recast to reflect changes in deferred compensation plan as a
Non-GAAP adjustment.
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
SUPPLEMENTAL FINANCIAL DATA
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Twelve Months Ended
|
|
|
|
January 1, 2012
|
|
October 2, 2011
|
|
January 2, 2011
|
|
January 1, 2012
|
|
January 2, 2011
|
|
Selected Cash Flow Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
$
|
65,922
|
|
|
$
|
106,114
|
|
|
$
|
69,187
|
|
|
$
|
284,249
|
|
|
$
|
262,746
|
|
|
Net cash provided by (used in) investing activities
|
|
$
|
1,731
|
|
|
$
|
(9,966
|
)
|
|
$
|
(96,099
|
)
|
|
$
|
69,100
|
|
|
$
|
(150,734
|
)
|
|
Net cash provided by (used in) financing activities
|
|
$
|
(32,196
|
)
|
|
$
|
(312,041
|
)
|
|
$
|
(23,485
|
)
|
|
$
|
(516,815
|
)
|
|
$
|
92,387
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Supplemental Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
8,758
|
|
|
$
|
18,207
|
|
|
$
|
13,666
|
|
|
$
|
80,556
|
|
|
$
|
50,786
|
|
|
Depreciation
|
|
$
|
9,872
|
|
|
$
|
12,894
|
|
|
$
|
12,402
|
|
|
$
|
48,632
|
|
|
$
|
47,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONSOLIDATED DILUTED EPS CALCULATION
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
January 1, 2012
|
|
October 2, 2011
|
|
January 2, 2011
|
|
|
January 1, 2012
|
|
January 2, 2011
|
|
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Cypress
|
|
$
|
30,961
|
|
$
|
56,119
|
|
$
|
39,981
|
|
$
|
69,237
|
|
$
|
9,053
|
|
$
|
50,389
|
|
|
$
|
167,139
|
|
$
|
236,835
|
|
$
|
75,742
|
|
$
|
186,310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding (basic)
|
|
|
154,045
|
|
|
154,045
|
|
|
163,867
|
|
|
163,867
|
|
|
165,873
|
|
|
165,873
|
|
|
|
164,495
|
|
|
164,495
|
|
|
161,114
|
|
|
161,144
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options, unvested restricted stock and other
|
|
|
18,034
|
|
|
21,416
|
|
|
19,415
|
|
|
22,131
|
|
|
31,683
|
|
|
36,377
|
|
|
|
22,400
|
|
|
26,192
|
|
|
30,263
|
|
|
36,832
|
|
Weighted-average common shares outstanding for diluted computation
|
|
|
172,079
|
|
|
175,461
|
|
|
183,282
|
|
|
185,998
|
|
|
197,556
|
|
|
202,250
|
|
|
|
186,895
|
|
|
190,687
|
|
|
191,377
|
|
|
197,976
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share attributable to Cypress - basic
|
|
$
|
0.20
|
|
$
|
0.36
|
|
$
|
0.24
|
|
$
|
0.42
|
|
$
|
0.05
|
|
$
|
0.30
|
|
|
$
|
1.02
|
|
$
|
1.44
|
|
$
|
0.47
|
|
$
|
1.16
|
|
Net income per share attributable to Cypress - diluted
|
|
$
|
0.18
|
|
$
|
0.32
|
|
$
|
0.22
|
|
$
|
0.37
|
|
$
|
0.05
|
|
$
|
0.25
|
|
|
$
|
0.89
|
|
$
|
1.24
|
|
$
|
0.40
|
|
$
|
0.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 1, 2012
|
|
October 2, 2011
|
|
January 2, 2011
|
|
|
January 1, 2012
|
|
January 2, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average stock price for the period ended
|
|
$17.68
|
|
$18.31
|
|
$15.51
|
|
|
$19.23
|
|
$12.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding at period end (in thousands)
|
|
154,172
|
|
155,268
|
|
170,363
|
|
|
154,172
|
|
170,363
|
|
Includes unvested restricted stock awards of approximately 0.9
million shares at January 1, 2012 and at October 3, 2011, and 1.0
million shares at January 2, 2011.
|
|
|
|
|
|
|
Notes to Non-GAAP Financial Measures
To supplement its consolidated financial results presented in accordance
with GAAP, Cypress uses non-GAAP financial measures which are adjusted
from the most directly comparable GAAP financial measures to exclude
certain items, as described in details below. Management believes that
these non-GAAP financial measures reflect an additional and useful way
of viewing aspects of Cypress’s operations that, when viewed in
conjunction with Cypress’s GAAP results, provide a more comprehensive
understanding of the various factors and trends affecting Cypress’s
business and operations. Non-GAAP financial measures used by Cypress
include:
• Research and development expenses;
• Selling, general and administrative expenses;
• Operating income (loss);
• Net income (loss); and
• Diluted net income (loss) per share.
Cypress uses each of these non-GAAP financial measures for internal
managerial purposes, when providing its financial results and business
outlook to the public, and to facilitate period-to-period comparisons.
Management believes that these non-GAAP measures provide meaningful
supplemental information regarding Cypress’s operational and financial
performance of current and historical results. Management uses these
non-GAAP measures for strategic and business decision making, internal
budgeting, forecasting and resource allocation processes. In addition,
these non-GAAP financial measures facilitate management’s internal
comparisons to Cypress’s historical operating results and comparisons to
competitors’ operating results.
Cypress believes that providing these non-GAAP financial measures, in
addition to the GAAP financial results, are useful to investors because
they allow investors to see Cypress’s results "through the eyes” of
management as these non-GAAP financial measures reflect Cypress’s
internal measurement processes. Management believes that these non-GAAP
financial measures enable investors to better assess changes in each key
element of Cypress’s operating results across different reporting
periods on a consistent basis. Thus, management believes that each of
these non-GAAP financial measures provides investors with another method
for assessing Cypress’s operating results in a manner that is focused on
the performance of its ongoing operations.
There are limitations in using non-GAAP financial measures because they
are not prepared in accordance with GAAP and may be different from
non-GAAP financial measures used by other companies. In addition,
non-GAAP financial measures may be limited in value because they exclude
certain items that may have a material impact upon Cypress’s reported
financial results. Management compensates for these limitations by
providing investors with reconciliations of the non-GAAP financial
measures to the most directly comparable GAAP financial measures. The
presentation of non-GAAP financial information is not meant to be
considered in isolation or as a substitute for the most directly
comparable GAAP financial measures. The non-GAAP financial measures
supplement, and should be viewed in conjunction with, GAAP financial
measures. Investors should review the reconciliations of the non-GAAP
financial measures to their most directly comparable GAAP financial
measures as provided in the accompanying press release.
As presented in the "Reconciliation of GAAP Financial Measures to
Non-GAAP Financial Measures” tables in the accompanying press release,
each of the non-GAAP financial measures excludes one or more of the
following items:
-
Stock-based compensation expense.
Stock-based compensation
expense relates primarily to the equity awards such as stock options
and restricted stock. Stock-based compensation is a non-cash expense
that varies in amount from period to period and is dependent on market
forces that are often beyond Cypress’s control. As a result,
management excludes this item from Cypress’s internal operating
forecasts and models. Management believes that non-GAAP measures
adjusted for stock-based compensation provide investors with a basis
to measure Cypress’s core performance against the performance of other
companies without the variability created by stock-based compensation
as a result of the variety of equity awards used by companies and the
varying methodologies and subjective assumptions used in determining
such non-cash expense.
-
Changes in value of Cypress’s key employee deferred compensation plan.
Cypress
sponsors a voluntary deferred compensation plan which provides certain
key employees with the option to defer the receipt of compensation in
order to accumulate funds for retirement. The amounts are held in a
trust and Cypress does not make contributions to the deferred
compensation plan or guarantee returns on the investment. Changes in
the value of the investments under the plan are excluded from the
non-GAAP measures. Management believes that such non-cash item is not
related to the ongoing core business and operating performance of
Cypress, as the investment contributions are made by the employees
themselves.
-
Restructuring charges.
Restructuring charges primarily relate to
activities engaged by management to make changes related to its
infrastructure in an effort to reduce costs. Restructuring charges are
excluded from non-GAAP financial measures because they are not
considered core operating activities and such costs have not
historically occurred in each year. Although Cypress has engaged in
various restructuring activities in the past, each has been a discrete
event based on a unique set of business objectives. As such,
management believes that it is appropriate to exclude restructuring
charges from Cypress’s non-GAAP financial measures, as it enhances the
ability of investors to compare Cypress’s period-over-period operating
results from continuing operations.
-
SRAM legal settlement.
Cypress has settled the SRAM civil
antitrust lawsuits. Cypress excludes these items because the legal
settlements are not reflective of its ongoing operating results.
Excluding this data allows investors to better compare Cypress’s
period-over-period performance without such expense.
-
Building donation.
Cypress committed to donate an unused building
to a charitable entity. Cypress excludes these items because the
expense is not reflective of its ongoing operating results. Excluding
this data allows investors to better compare Cypress’s
period-over-period performance without such expense.
-
Acquisition-related expense.
Acquisition-related expense
primarily includes: (1) amortization of intangibles, which include
acquired intangibles such as purchased technology, patents and
trademarks, and (2) earn-out compensation expense, which include
compensation resulting from the achievement of milestones established
in accordance with the terms of the acquisitions. In most cases, these
acquisition-related charges are not factored into management’s
evaluation of potential acquisitions or Cypress’s performance after
completion of acquisitions, because they are not related to Cypress’s
core operating performance. Adjustments of these items provide
investors with a basis to compare Cypress against the performance of
other companies without the variability caused by purchase accounting.
-
Investment-related gains/losses.
Investment-related gains/losses
primarily include: (1) impairment loss related to Cypress’s investment
when it determines the decline in fair value is other-than-temporary
in nature, and (2) gains/losses related to the sales of its debt and
equity investments. These items are excluded from non-GAAP financial
measures because they are not related to the core operating activities
and operating performance of Cypress, and in most cases, such
transactions have not historically occurred in every quarter. As such,
management believes that it is appropriate to exclude
investment-related gains/losses from Cypress’s non-GAAP financial
measures, as it enhances the ability of investors to compare Cypress’s
period-over-period operating results.
-
Impairment of assets.
Cypress wrote down the book value of
certain assets to its estimated fair value as management determined
these assets will be donated, sold or will have no future benefit.
Cypress excludes these items because the expense is not reflective of
its ongoing operating results. Excluding this data allows investors to
better compare Cypress’s period-over-period performance without such
expense.
-
Gains and losses on sales of long-term assets.
Cypress recognizes
gains resulting from the sale of certain long-term assets that no
longer align with Cypress’s long-term operating plan. Cypress excludes
these items from its non-GAAP financial measures primarily because it
is not reflective of the ongoing operating performance of Cypress’s
business and can distort the period-over-period comparison.
-
Tax effects.
Cypress adjusts for the income tax effect that
resulted from the non-GAAP adjustments as described above.
Additionally, Cypress also excludes the impact of items that are
related to historical activities in nature and not reflective of the
ongoing operating results of Cypress.
